Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00569777 · ClinicalTrials.gov registry record · Phase 3
Safety Study of a Contact Lens With Ketotifen in Healthy, Normal Volunteers
A Phase 3 study, sponsored by Vistakon Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 310
- Enrollment target
NCT00569777: Completed Phase 3 study, sponsored by Vistakon Pharmaceuticals.
NCT00569777 is a Phase 3 study that has completed, run by Vistakon Pharmaceuticals. The registered enrollment target is 310 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (60% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00569777, a Phase 3 study, has completed, sponsored by Vistakon Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 310 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety of a novel contact lens in healthy normal volunteers
Primary Outcome
Assessment of lid redness using the following scale: 0=none, 1=mild, 2=moderate, 3=severe, 4=very severe.
Interventions
- DEVICE K-Lens (generic name not established) and Ketotifen
- DEVICE Placebo Lens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 310 participants |
| Start Date | 2007-10 |
| Est. Completion | 2008-03 |
| Phase | Phase 3 |
What the finished NCT00569777 record still lists
NCT00569777 is an interventional study that assigns participants to a tested intervention. The registered 310 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (60% lower).
The record links to 0 conditions, and to 2 interventions - of which K-Lens (generic name not established) and Ketotifen is the first listed.
NCT00569777 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00569777 about?
NCT00569777 is a clinical study titled "Safety Study of a Contact Lens With Ketotifen in Healthy, Normal Volunteers". The purpose of this study is to evaluate the safety of a novel contact lens in healthy normal volunteers
What is the current status of trial NCT00569777?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 310 participants. The study started on 2007-10. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00569777?
The interventions under investigation include: K-Lens (generic name not established) and Ketotifen (DEVICE), Placebo Lens (DEVICE).
Who is sponsoring clinical trial NCT00569777?
This trial is sponsored by Vistakon Pharmaceuticals, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00569777's enrollment target sits among peer trials
310 1107th of 2000 higher than 892 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03039439 · 310 participants
Molecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid Tumors
- NCT04178018 · 310 participants · NA
Transvaginal Ultrasound and Photoacoustic Imaging of Ovary
- NCT04878094 · 310 participants · Phase 3
A Study of Intra-operative Imaging in Women With Ovarian Cancer
- NCT05459233 · 310 participants · NA
Valve Hemodynamic Optimization Based on Doppler-Echocardiography vs Catheterization Measurements Following ViV TAVR
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia